Bg pattern

MENSIFEM FILM-COATED TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MENSIFEM FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Mensifem

film-coated tablets

Dry extract of Cimicifuga racemosa L. rhizome

Read the entire package leaflet carefully before starting to take this medicine, as it contains important information for you.

Follow the administration instructions of the medicine contained in this package leaflet or as indicated by your doctor or pharmacist.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.
  • You should consult a doctor if you do not improve after 6 to 8 weeks or if you worsen.

Contents of the package leaflet

  1. What is Mensifem and what is it used for
  2. What you need to know before taking Mensifem
  3. How to take Mensifem
  4. Possible side effects
  5. Storage of Mensifem
  6. Package contents and additional information

1. What is Mensifem and what is it used for

Mensifem is a herbal medicine indicated in adult women for the relief of menopausal symptoms, such as hot flashes and intense sweating.

You should consult a doctor if you worsen or do not improve after 6 to 8 weeks (40 to 60 days) of treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Mensifem

Do not take Mensifem

  • if you are allergic (hypersensitive) to Cimicifuga racemosaor to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor before starting to take Mensifem:

  • If you have a history of liver disease. In such cases, a liver function test should be performed before starting treatment.
  • If you detect signs or develop symptoms of liver damage (fatigue, loss of appetite, yellowing of the skin and eyes, or severe pain in the upper abdomen with nausea and vomiting or dark urine). Stop taking Mensifem and consult your doctor immediately.
  • If you experience vaginal bleeding or detect new or non-specific symptoms.
  • If you have been or are being treated for breast cancer or other hormone-dependent tumors.
  • If you are taking estrogens.
  • If symptoms worsen during the use of this medicine.

If any of the above cases apply to you, do not take Mensifem without a medical prescription.

If symptoms persist or worsen during treatment, consult your doctor or pharmacist.

Children and adolescents

There is no interest in using Mensifem in the pediatric population for the proposed therapeutic indication.

Taking Mensifem with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine. Medicines can interact with each other if taken at the same time. However, no interactions have been reported, and no interaction studies have been conducted with Mensifem.

Pregnancy, breastfeeding, and fertility

Do not take Mensifem if you are pregnant. It is unknown if the active ingredient is excreted in breast milk. Mensifem should not be taken during the breastfeeding period. If there is a possibility of becoming pregnant, even during menopause, effective contraceptive methods should be used during treatment.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

No studies have been conducted on the effects on the ability to drive and use machines.

Mensifem contains lactose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

Mensifem contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per film-coated tablet, which is essentially "sodium-free".

3. How to take Mensifem

Follow the administration instructions of the medicine contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

The usual dose for adult women in menopause is 1 film-coated tablet twice a day, i.e., one in the morning and one in the evening (maximum 2 film-coated tablets per day).

Method of administration:

Oral. The film-coated tablets are taken whole, without chewing or sucking, with some liquid.

Duration of treatment:

If symptoms persist during the use of the medicine, consult a doctor or pharmacist.

Mensifem should not be taken for more than six months in a row without medical indication.

Use in children and adolescents

There is no interest in using Mensifem in the pediatric population for the proposed therapeutic indication.

Special populations

There are insufficient data to establish specific dosage recommendations in patients with renal or hepatic impairment.

Patients with a history of liver disease should not take Mensifem without medical indication (see section 2 "Warnings and precautions" and section 4 "Possible side effects").

If you take more Mensifem than you should:

No cases of overdose have been reported. Inform your doctor if you took a higher dose of this medicine than recommended. Your doctor will decide what measures to take.

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Phone 915 620 420, indicating the medicine and the amount used.

If you forget to take Mensifem:

Do not take a double dose to make up for forgotten doses. Take the next tablet at the usual time.

If you stop taking Mensifem:

As a general rule, it is harmless to stop taking Mensifem.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

The frequency of the following side effects is unknown:

  • The use of products containing Cimicifuga racemosa rhizome is associated with liver toxicity (including hepatitis, jaundice, fatigue, loss of appetite, pain in the upper abdomen with nausea and vomiting, dark urine, and changes in liver function tests).
  • Cutaneous allergic reactions (urticaria, pruritus, skin rash).
  • Inflammation of the facial tissues and lower limbs (known as edema).
  • Gastrointestinal symptoms (e.g., dyspeptic disorders, diarrhea).

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Mensifem

Keep this medicine out of the sight and reach of children.

Do not store above 30°C.

Keep the blisters in the outer packaging to protect them from light.

Do not use this medicine after the expiration date stated on the carton. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package contents and additional information

Composition of Mensifem

The active ingredient is:

2.8 mg of dry extract of Cimicifuga racemosa(L.) Nutt., rhizome (black cohosh) (5-10:1) *1

extraction solvent: ethanol 58% (v/v)

The other ingredients are calcium hydrogen phosphate dihydrate; ammonium methacrylate copolymer, type A, dispersion 3% (Eudragit RL 30D); red iron oxide (E 172); yellow iron oxide (E 172); lactose monohydrate; polyethylene glycol (macrogol 6000); magnesium stearate (vegetable); potato starch; sodium hydroxide; sorbic acid; talc; titanium dioxide (E 171).

Appearance of the product and package contents

Mensifem film-coated tablets are available in PVC/PVDC/aluminum blisters.

Box of 60 film-coated tablets

Box of 90 film-coated tablets

Only some package sizes may be marketed.

The tablets are terracotta-colored, round, and biconvex with a smooth surface. The film-coated tablet has a diameter of between 7.0 and 7.2 mm.

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria Mensifem Filmtabletten

Belgium, Germany, Luxembourg, Poland, Slovenia, Estonia

Croatia, Denmark, Norway, Sweden Klimadynon

Bulgaria ??????????

Spain, France, Italy Mensifem

Slovakia, Czech Republic Menofem

Latvia Klimadynon 2.8 mg apvalkotas tablets

Lithuania Klimadynon 2.8 mg plévele dengtos tablets

Marketing authorization holder and manufacturer

BIONORICA SE

Kerschensteinerstrasse 11-15

92318 Neumarkt

Germany

Phone: +49 / (0)9181 / 231-90

Fax: +49 / (0)9181 / 231-265

Email: [email protected]

Date of the last revision of this package leaflet:December 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MENSIFEM FILM-COATED TABLETS

Discuss questions about MENSIFEM FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (53)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
5.0 (26)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

5.0 (43)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80

Get MENSIFEM FILM-COATED TABLETS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for MENSIFEM FILM-COATED TABLETS?

MENSIFEM FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in MENSIFEM FILM-COATED TABLETS?

The active ingredient in MENSIFEM FILM-COATED TABLETS is Cimicifugae rhizoma. This information helps identify medicines with the same composition but different brand names.

Who manufactures MENSIFEM FILM-COATED TABLETS?

MENSIFEM FILM-COATED TABLETS is manufactured by Bionorica Se. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of MENSIFEM FILM-COATED TABLETS online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MENSIFEM FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy MENSIFEM FILM-COATED TABLETS in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy MENSIFEM FILM-COATED TABLETS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to MENSIFEM FILM-COATED TABLETS?

Other medicines with the same active substance (Cimicifugae rhizoma) include REMIFEMIN COMPRESSED TABLETS, AGNUCASTON 20 mg FILM-COATED TABLETS, ATOSIBAN ALTAN 37.5 mg/5 ml CONCENTRATE FOR INFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media